TIL
Instil Bio, Inc.
Price Chart
Latest Quote
$7.55
-0.01 (-0.13%)
Current Price
| Previous Close | $7.56 |
| Open | $7.61 |
| Day High | $7.75 |
| Day Low | $7.53 |
| Volume | 12,084 |
Stock Information
| Shares Outstanding | 6.78M |
| Total Debt | $85.19M |
| Cash Equivalents | $74.57M |
| Net Income | $-47.38M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $51.20M |
| EPS (TTM) | $-7.00 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $62.22M |
| Income | $-47.38M |
| Book/sh | $16.79 |
| Cash/sh | $11.00 |
| Employees | 17 |
Financial Ratios
| Quick Ratio | 15.79 |
| Current Ratio | 39.87 |
| Debt/Eq | 76.95 |
Returns & Margins
| ROA | -12.69% |
| ROE | -37.07% |
Ownership
| Insider Ownership | 6.29% |
| Institutional Ownership | 62.20% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.52 |
| P/B | 0.45 |
Analyst Data
| Recommendation | none |
| Target Price | $7.00 |
Technical Indicators
| SMA20 | $8.00 |
| SMA50 | $8.11 |
| SMA200 | $11.69 |
| RSI | 19.77 |
| ATR | 0.1922 |
| Shares Float | 3.62M |
| Short Float | 5.78% |
| Short Ratio | 7.14 |
| Volatility | 1.91 |
| Rel Volume | 0.59 |
Performance History
| Week | -4.79% |
| Month | -5.86% |
| Quarter | -10.97% |
| 6 Months | -32.89% |
| YTD | -33.01% |
| Year | -72.89% |
| 3 Years | -33.89% |
| 5 Years | -97.78% |
| 10 Years | -98.57% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $7.55 | 12,084 |
| 2026-06-17 | $7.56 | 22,000 |
| 2026-06-16 | $7.61 | 71,300 |
| 2026-06-15 | $7.92 | 28,500 |
| 2026-06-12 | $7.92 | 12,400 |
| 2026-06-11 | $7.93 | 8,100 |
| 2026-06-10 | $7.98 | 8,100 |
| 2026-06-09 | $8.02 | 16,200 |
| 2026-06-08 | $8.08 | 10,400 |
| 2026-06-05 | $8.07 | 6,300 |
| 2026-06-04 | $8.14 | 10,200 |
| 2026-06-03 | $8.23 | 14,700 |
| 2026-06-02 | $8.11 | 15,200 |
| 2026-06-01 | $8.11 | 16,400 |
| 2026-05-29 | $8.07 | 16,300 |
| 2026-05-28 | $8.10 | 25,600 |
| 2026-05-27 | $8.14 | 12,200 |
| 2026-05-26 | $8.12 | 26,900 |
| 2026-05-22 | $8.18 | 17,900 |
| 2026-05-21 | $8.12 | 59,200 |
| 2026-05-20 | $8.02 | 87,700 |
| 2026-05-19 | $8.02 | 59,800 |
| 2026-05-18 | $8.13 | 50,500 |
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
đ° Latest News
CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround
Motley Fool âĸ 2026-02-03T15:20:49Z
Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.
Motley Fool âĸ 2026-02-03T15:06:20Z
Instil Bio, Inc. (NASDAQ:TIL) is definitely on the radar of institutional investors who own 36% of the company
Simply Wall St. âĸ 2025-08-16T12:23:32Z
Instil Bio, Inc. (TIL) Is Up 4.07% in One Week: What You Should Know
Zacks âĸ 2025-06-20T16:00:04Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $5,038,000 | $7,997,000 | $4,214,000 | $1,883,000 |
| Total Expenses | $51,959,000 | $56,048,000 | $87,157,000 | $203,291,000 |
| Other Income Expense | $-17,442,000 | $-16,082,000 | $-72,587,000 | $-23,731,000 |
| Other Non Operating Income Expenses | $9,180,000 | $1,411,000 | $-575,000 | $-564,000 |
| Net Non Operating Interest Income Expense | $-1,971,000 | $-2,005,000 | $3,657,000 | $1,772,000 |
| Total Other Finance Cost | $791,000 | $995,000 | $995,000 | - |
| Interest Expense Non Operating | $5,038,000 | $7,997,000 | $4,214,000 | $1,883,000 |
| Operating Expense | $51,959,000 | $56,048,000 | $87,157,000 | $203,291,000 |
| General And Administrative Expense | $27,221,000 | $44,210,000 | $47,553,000 | $62,235,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Net Interest Income | $-1,971,000 | $-2,005,000 | $3,657,000 | $1,772,000 |
| Interest Income | $3,858,000 | $6,987,000 | $8,866,000 | $3,655,000 |
| Normalized Income | $-44,750,000 | $-56,642,000 | $-84,075,000 | $-200,218,503 |
| Net Income From Continuing And Discontinued Operation | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Total Operating Income As Reported | $-78,581,000 | $-73,541,000 | $-159,169,000 | $-226,458,000 |
| Net Income Common Stockholders | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Net Income | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Net Income Including Noncontrolling Interests | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Net Income Continuous Operations | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Pretax Income | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-225,250,000 |
| Special Income Charges | $-26,622,000 | $-17,493,000 | $-72,012,000 | $-23,167,000 |
| Interest Income Non Operating | $3,858,000 | $6,987,000 | $8,866,000 | $3,655,000 |
| Operating Income | $-51,959,000 | $-56,048,000 | $-87,157,000 | $-203,291,000 |
| Per Share | ||||
| Diluted EPS | $-10.70 | $-11.39 | $-24.00 | $-34.40 |
| Basic EPS | $-10.70 | $-11.39 | $-24.00 | $-34.40 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $-208,503 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-39,178,000 | $-45,035,000 | $-75,105,000 | $-194,213,000 |
| Total Unusual Items | $-26,622,000 | $-17,493,000 | $-72,012,000 | $-23,167,000 |
| Total Unusual Items Excluding Goodwill | $-26,622,000 | $-17,493,000 | $-72,012,000 | $-23,167,000 |
| Reconciled Depreciation | $534,000 | $3,610,000 | $4,756,000 | $5,987,000 |
| EBITDA (Bullshit earnings) | $-65,800,000 | $-62,528,000 | $-147,117,000 | $-217,380,000 |
| EBIT | $-66,334,000 | $-66,138,000 | $-151,873,000 | $-223,367,000 |
| Diluted Average Shares | $6,668,268 | $6,510,138 | $6,503,913 | $6,475,630 |
| Basic Average Shares | $6,668,268 | $6,510,138 | $6,503,913 | $6,475,630 |
| Diluted NI Availto Com Stockholders | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Other Special Charges | $10,000,000 | $10,000,000 | - | - |
| Impairment Of Capital Assets | $16,569,000 | $5,495,000 | $68,181,000 | - |
| Restructuring And Mergern Acquisition | $53,000 | $1,998,000 | $3,831,000 | $23,167,000 |
| Research And Development | $24,738,000 | $11,838,000 | $39,604,000 | $141,056,000 |
| Selling General And Administration | $27,221,000 | $44,210,000 | $47,553,000 | $62,235,000 |
| Other Gand A | $27,221,000 | $44,210,000 | $47,553,000 | $62,235,000 |
| Tax Provision | - | - | $0 | $-2,073,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $113,866,000 | $169,436,000 | $225,829,000 | $363,605,000 |
| Total Assets | $203,523,000 | $263,567,000 | $325,630,000 | $482,128,000 |
| Total Non Current Assets | $12,094,000 | $139,097,000 | $164,871,000 | $212,750,000 |
| Other Non Current Assets | $4,066,000 | $4,490,000 | $639,000 | $3,413,000 |
| Non Current Accounts Receivable | $7,664,000 | $4,267,000 | - | - |
| Current Assets | $191,429,000 | $124,470,000 | $160,759,000 | $269,378,000 |
| Other Current Assets | $148,000 | $9,325,000 | $8,902,000 | $8,458,000 |
| Assets Held For Sale Current | $112,096,000 | $0 | - | - |
| Restricted Cash | $166,000 | $1,830,000 | $1,501,000 | $0 |
| Prepaid Assets | $2,042,000 | $9,325,000 | $8,902,000 | $8,458,000 |
| Receivables | $848,000 | - | - | - |
| Taxes Receivable | $848,000 | - | - | - |
| Cash Cash Equivalents And Short Term Investments | $76,129,000 | $113,315,000 | $150,356,000 | $260,920,000 |
| Cash And Cash Equivalents | $6,638,000 | $8,805,000 | $9,195,000 | $43,716,000 |
| Investmentin Financial Assets | - | $0 | $23,161,000 | - |
| Goodwill And Other Intangible Assets | - | - | - | $0 |
| Other Intangible Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $78,168,000 | $75,382,000 | $72,232,000 | $28,634,000 |
| Total Debt | $85,178,000 | $86,886,000 | $86,054,000 | $79,902,000 |
| Long Term Debt And Capital Lease Obligation | $84,806,000 | $85,204,000 | $84,304,000 | $77,521,000 |
| Long Term Debt | $84,806,000 | $84,187,000 | $81,427,000 | $72,350,000 |
| Current Debt And Capital Lease Obligation | $372,000 | $1,682,000 | $1,750,000 | $2,381,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $89,657,000 | $94,131,000 | $99,801,000 | $118,523,000 |
| Total Non Current Liabilities Net Minority Interest | $84,814,000 | $86,235,000 | $89,242,000 | $85,735,000 |
| Other Non Current Liabilities | $8,000 | $1,031,000 | $4,938,000 | $8,214,000 |
| Current Liabilities | $4,843,000 | $7,896,000 | $10,559,000 | $32,788,000 |
| Payables And Accrued Expenses | $1,954,000 | $3,523,000 | $7,593,000 | $26,182,000 |
| Payables | $779,000 | $659,000 | $1,212,000 | $2,359,000 |
| Accounts Payable | $779,000 | $659,000 | $1,212,000 | $2,359,000 |
| Other Current Liabilities | - | - | $190,000 | $952,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Non Current Deferred Taxes Liabilities | - | - | - | $0 |
| Total Tax Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $113,866,000 | $169,436,000 | $225,829,000 | $363,605,000 |
| Total Equity Gross Minority Interest | $113,866,000 | $169,436,000 | $225,829,000 | $363,605,000 |
| Stockholders Equity | $113,866,000 | $169,436,000 | $225,829,000 | $363,605,000 |
| Gains Losses Not Affecting Retained Earnings | $-583,000 | $-228,000 | $-348,000 | $-493,000 |
| Other Equity Adjustments | $-583,000 | $-228,000 | $-348,000 | $-493,000 |
| Retained Earnings | $-726,488,000 | $-655,116,000 | $-580,981,000 | $-424,894,000 |
| Other | ||||
| Ordinary Shares Number | $6,781,976 | $6,525,887 | $6,503,913 | $6,503,954 |
| Share Issued | $6,781,976 | $6,525,887 | $6,503,913 | $6,503,954 |
| Tangible Book Value | $113,866,000 | $169,436,000 | $225,829,000 | $363,605,000 |
| Invested Capital | $198,672,000 | $253,623,000 | $307,256,000 | $435,955,000 |
| Working Capital | $186,586,000 | $116,574,000 | $150,200,000 | $236,590,000 |
| Capital Lease Obligations | $372,000 | $2,699,000 | $4,627,000 | $7,552,000 |
| Total Capitalization | $198,672,000 | $253,623,000 | $307,256,000 | $435,955,000 |
| Additional Paid In Capital | $840,937,000 | $824,780,000 | $807,158,000 | $788,992,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $1,017,000 | $2,877,000 | $5,171,000 |
| Current Capital Lease Obligation | $372,000 | $1,682,000 | $1,750,000 | $2,381,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,517,000 | $2,691,000 | $1,026,000 | $3,273,000 |
| Current Accrued Expenses | $1,175,000 | $2,864,000 | $6,381,000 | $23,823,000 |
| Net PPE | $364,000 | $130,340,000 | $141,071,000 | $209,337,000 |
| Accumulated Depreciation | $-383,000 | $-4,779,000 | $-7,555,000 | $-8,484,000 |
| Gross PPE | $747,000 | $135,119,000 | $148,626,000 | $217,821,000 |
| Other Properties | $238,000 | $934,000 | $12,695,000 | $40,310,000 |
| Machinery Furniture Equipment | $509,000 | $509,000 | $831,000 | $5,033,000 |
| Buildings And Improvements | $0 | $102,433,000 | $102,433,000 | $32,778,000 |
| Land And Improvements | $0 | $31,243,000 | $31,243,000 | $31,243,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $69,491,000 | $104,510,000 | $141,161,000 | $217,204,000 |
| Investments And Advances | - | $0 | $23,161,000 | $0 |
| Leases | - | $0 | $1,424,000 | $4,340,000 |
| Available For Sale Securities | - | - | $23,161,000 | - |
| Construction In Progress | - | - | $0 | $104,117,000 |
| Goodwill | - | - | - | $0 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-46,619,000 | $-65,696,000 | $-102,692,000 | $-264,753,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-36,619,000 | $-55,696,000 | $-82,029,000 | $-180,164,000 |
| Cash Flow From Continuing Operating Activities | $-36,619,000 | $-55,696,000 | $-82,029,000 | $-180,164,000 |
| Operating Gains Losses | $-484,000 | $2,088,000 | $844,000 | $-23,000 |
| Investing Activities | ||||
| Capital Expenditure | $-10,000,000 | $-10,000,000 | $-20,663,000 | $-84,589,000 |
| Investing Cash Flow | $25,476,000 | $53,974,000 | $41,128,000 | $114,541,000 |
| Cash Flow From Continuing Investing Activities | $25,476,000 | $53,974,000 | $41,128,000 | $114,541,000 |
| Net Other Investing Changes | $432,000 | $866,000 | $1,557,000 | - |
| Financing Activities | ||||
| Financing Cash Flow | $7,292,000 | $1,755,000 | $8,082,000 | $71,886,000 |
| Cash Flow From Continuing Financing Activities | $7,292,000 | $1,755,000 | $8,082,000 | $71,886,000 |
| Net Other Financing Charges | $6,439,000 | $-1,372,000 | - | - |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $0 | $-82,838,000 | $-587,000 | $0 |
| Issuance Of Debt | $0 | $85,600,000 | $8,669,000 | $70,338,000 |
| Interest Paid Supplemental Data | $5,038,000 | $7,997,000 | $6,639,000 | $1,068,000 |
| End Cash Position | $6,804,000 | $10,635,000 | $10,696,000 | $43,716,000 |
| Beginning Cash Position | $10,635,000 | $10,696,000 | $43,716,000 | $38,090,000 |
| Effect Of Exchange Rate Changes | $20,000 | $-94,000 | $-201,000 | $-637,000 |
| Changes In Cash | $-3,851,000 | $33,000 | $-32,819,000 | $6,263,000 |
| Proceeds From Stock Option Exercised | $853,000 | $365,000 | $0 | $1,548,000 |
| Net Issuance Payments Of Debt | $0 | $2,762,000 | $8,082,000 | $70,338,000 |
| Net Long Term Debt Issuance | $0 | $2,762,000 | $8,082,000 | $70,338,000 |
| Long Term Debt Payments | $0 | $-82,838,000 | $-587,000 | $0 |
| Long Term Debt Issuance | $0 | $85,600,000 | $8,669,000 | $70,338,000 |
| Net Investment Purchase And Sale | $35,044,000 | $63,108,000 | $60,234,000 | $199,130,000 |
| Sale Of Investment | $135,900,000 | $198,705,000 | $361,700,000 | $865,350,000 |
| Purchase Of Investment | $-100,856,000 | $-135,597,000 | $-301,466,000 | $-666,220,000 |
| Net Intangibles Purchase And Sale | $-10,000,000 | $-10,000,000 | $0 | - |
| Purchase Of Intangibles | $-10,000,000 | $-10,000,000 | $0 | - |
| Change In Working Capital | $-560,000 | $-12,605,000 | $-9,016,000 | $-9,566,000 |
| Change In Other Current Liabilities | $-1,472,000 | $-1,300,000 | $-1,416,000 | $1,293,000 |
| Change In Other Current Assets | $425,000 | $-4,363,000 | $1,543,000 | $354,000 |
| Change In Payables And Accrued Expense | $-2,231,000 | $-2,454,000 | $-8,902,000 | $-10,783,000 |
| Change In Accrued Expense | $-2,347,000 | $-1,898,000 | $-7,773,000 | $-8,977,000 |
| Change In Payable | $116,000 | $-556,000 | $-1,129,000 | $-1,806,000 |
| Change In Account Payable | $116,000 | $-556,000 | $-1,129,000 | $-1,806,000 |
| Change In Prepaid Assets | $6,115,000 | $-221,000 | $-241,000 | $-430,000 |
| Change In Receivables | $-3,397,000 | $-4,267,000 | - | - |
| Other Non Cash Items | $10,001,000 | $2,937,000 | $-8,504,000 | $-1,559,000 |
| Stock Based Compensation | $8,693,000 | $17,257,000 | $18,166,000 | $30,441,000 |
| Asset Impairment Charge | $16,569,000 | $5,152,000 | $67,812,000 | $17,733,000 |
| Depreciation Amortization Depletion | $534,000 | $3,610,000 | $4,756,000 | $5,987,000 |
| Depreciation And Amortization | $534,000 | $3,610,000 | $4,756,000 | $5,987,000 |
| Depreciation | $534,000 | $3,610,000 | $4,756,000 | $5,987,000 |
| Net Foreign Currency Exchange Gain Loss | $-484,000 | $275,000 | $-680,000 | $1,391,000 |
| Gain Loss On Sale Of PPE | $0 | $343,000 | $377,000 | $0 |
| Net Income From Continuing Operations | $-71,372,000 | $-74,135,000 | $-156,087,000 | $-223,177,000 |
| Net PPE Purchase And Sale | - | $0 | $-20,663,000 | $-84,589,000 |
| Purchase Of PPE | - | $0 | $-20,663,000 | $-84,589,000 |
| Gain Loss On Investment Securities | - | $1,055,000 | $1,147,000 | $-1,414,000 |
| Net Business Purchase And Sale | - | - | - | - |
| Purchase Of Business | - | - | - | - |
Fetched: 2026-06-18